Department of Neurosurgery, Ludwig-Maximilians-University Munich, Marchioninistrasse 15, 81377, Munich, Germany,
J Neurol. 2013 Nov;260(11):2815-22. doi: 10.1007/s00415-013-7071-3. Epub 2013 Aug 22.
Brainstem cavernous malformations are associated with a considerable risk of hemorrhage and subsequent morbidity. This study provides a detailed work-up of clinical and radiological outcome as well as identification of prognostic factors in patients who had suffered from symptomatic hemorrhages. Patients who had undergone surgery of symptomatic BSCMs were evaluated pre- and postoperatively both neurologically and neuroradiologically supplemented by telephone interviews. Additionally, patients were scored according to the Scandinavian Stroke Scale. Multiple uni- and multivariate analyses of possible clinical and radiological prognostic factors were conducted. The study population comprised 35 patients. Mean age at operation was 39.3 ± 13.0 years with microsurgical resection of a total of 37 different BSCMs between 2002 and 2011. Median clinical follow-up was 44.0 months (range 8-116 months). Postoperative MRI showed eventually complete resection of all BSCMs. Postoperative overall outcome revealed complete resolution of neurological symptoms for 5/35 patients, 14/35 improved and 9/35 remained unchanged. 7/35 suffered from a postoperative new and permanent neurological deficit, mostly affecting the facial nerve or hemipareses with mild impairment. Pre- and postoperative Scandinavian Stroke Scale scores were 11.0 ± 2.4 and 11.4 ± 2.2 (p = 0.55). None of the analyzed factors were found to significantly correlate with patients' clinical outcome. Complete resection of brainstem cavernous malformations can be achieved with an acceptable risk for long-term morbidity and surgery-related new deficits (~20 %). Neurological outcome is mainly determined within the first 6 months after surgery. Surgical treatment of brainstem cavernous malformations is recommended in symptomatic patients, in whom the lesion is accessible for surgery.
脑干海绵状血管畸形与大量出血及随后发病的风险相关。本研究详细阐述了有症状性出血患者的临床和放射学结局以及预后因素的识别。对有症状性脑干海绵状血管畸形接受手术的患者进行了术前和术后神经学和神经放射学评估,还通过电话访谈进行了补充。此外,根据斯堪的纳维亚卒中量表对患者进行了评分。对可能的临床和放射学预后因素进行了多次单变量和多变量分析。该研究纳入了 35 名患者。手术时的平均年龄为 39.3±13.0 岁,2002 年至 2011 年间共切除了 37 个不同的脑干海绵状血管畸形。中位临床随访时间为 44.0 个月(8-116 个月)。术后 MRI 最终显示所有脑干海绵状血管畸形完全切除。术后总体结果显示,5/35 例患者的神经症状完全缓解,14/35 例患者改善,9/35 例患者无变化。7/35 例患者术后出现新的永久性神经功能缺损,主要影响面神经或偏瘫,伴轻度损伤。术前和术后斯堪的纳维亚卒中量表评分分别为 11.0±2.4 和 11.4±2.2(p=0.55)。分析的因素均与患者的临床结局无显著相关性。脑干海绵状血管畸形的完全切除可在长期发病率和手术相关新缺陷的可接受风险下实现(约 20%)。神经学结局主要在术后 6 个月内确定。建议对有症状且病变可手术的患者进行手术治疗。